Biotech Raises $85 Million To Develop Anti-Aging Technology
The San Diego based biotech Epirium has raised $85 million to pursue anti-aging approaches to slow down, delay, or reverse the process of aging, led by Longitude Capital and ARCH Venture Partners to advance clinical trial of their drug candidate which will be initially tested in Becker muscular dystrophy. Aging is similar to muscular dystrophy …